- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05169047
Undertærskel SCS eller BMT (TRADITION)
Den holistiske reaktion fra patienter med vedvarende spinal smertesyndrom type II ved subthreshold rygmarvsstimulering sammenlignet med bedste medicinske behandling, undersøgt af et multicentrisk randomiseret kontrolleret forsøg
Given the substantial socioeconomic impact of Spinal Cord Stimulation (SCS) implantations and given that currently no direct high-quality evidence with a relevant outcome measurement is available to guide the treatment choice between subthreshold SCS versus best medical treatment in patients with Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), we here propose a scientifically well-constructed randomized controlled trial to answer this question.
The primary scientific objective is to examine whether subthreshold SCS, compared to best medical treatment, provided to patients with PSPS-T2 results in a higher percentage of clinical holistic responders at 6 months. The secondary objective of the study is to examine if subthreshold SCS compared with BMT is having more efficacy in improving patients' individual competencies for self-management, increasing the likelihood to return to work, work status and healthcare expenditure, improving pain relief, obtaining pain medication reduction, decreasing anxiety and depression, increasing quality of life and decreasing disability.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
After filling in the questionnaires at the 6 months follow-up visit, patients could change treatment groups (in both directions). This decision will be a shared decisions between patient and treating physician in case the randomized intervention did not provided enough pain relief.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Jette, Belgien, 1090
- Universitair Ziekenhuis Brussel
-
Mechelen, Belgien
- Emmaüs, AZ Sint-Maarten
-
Roeselare, Belgien
- AZ Delta
-
Turnhout, Belgien
- AZ Turnhout
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Persistent Spinal Pain Syndrome Type II (PSPS-T2)
- Chronic pain as a result of PSPS-T2 that exists for at least 6 months with a pain intensity of at least 4/10 on the Numeric Rating Scale, refractory to conservative treatment.
- PSPS-T2 patients eligible for subthreshold SCS
- Age > 18 years
- Patient has been informed of the study procedures and has given written informed consent
- Patient willing to comply with study protocol including attending the study visits
Exclusion Criteria:
- Expected inability of patients to receive or properly operate the spinal cord stimulation system
- Evidence of an active psychiatric disorder
- Suffering from another chronic illness characterised by chronic generalized widespread pain (e.g. rheumatoid arthritis, fibromyalgia, chronic fatigue syndrome, scleroderma).
- Pregnancy
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Bedste medicinske behandling
|
For each patient who is randomized to BMT, an optimal individual treatment plan will be developed by the treating physician. |
|
Aktiv komparator: Subthreshold rygmarvsstimulering
|
SCS will be programmed at subthreshold stimulation. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Clinical holistic responder status
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The clinical holistic responder status as a composite measure represents the global effect of a treatment, based on a combination of questionnaires. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall pain intensity with Visual Analogue Scale (VAS)
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Overall pain, defined as a combination of back and leg pain, but not pain from other body parts, measured with the VAS (100mm) |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Pain medication use
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Open question regarding the dosage, frequency and type of pain medication |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Functional disability
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The functional disabilities will be assessed with the Oswestry Disability Index (ODI) |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Health related quality of life
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Health related quality of life, evaluated with the EuroQol with five dimensions and 5 levels |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Patient global impression of change
Tidsramme: Evaluated at 1 month, 6 months and 12 months.
|
Patients will be asked to quantify the impression of change after treatment using the Patient Global Impression of Change scale (PGIC). |
Evaluated at 1 month, 6 months and 12 months.
|
|
Work status
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Work status is evaluated with a self-designed questionnaire |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Patients' individual competencies for self-management
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Patient activation measure-13 (PAM) is a 13-item instrument which assesses self-reported behaviour, knowledge, and confidence for self-management of one's health. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Healthcare utilisation.
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Healthcare expenditure will be investigated by self-reporting methods. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Anxiety and Depression.
Tidsramme: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The hospital Anxiety and Depression Scale (HADS) will measure symptoms of anxiety and depression |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Samarbejdspartnere og efterforskere
Sponsor
Publikationer og nyttige links
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- TRADITION
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .